+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Steatohepatitis Drugs"

Nonalcoholic Steatohepatitis - Pipeline Insight, 2021 - Product Thumbnail Image

Nonalcoholic Steatohepatitis - Pipeline Insight, 2021

  • Clinical Trials
  • May 2021
  • 230 pages
From
Global Nonalcoholic Steatohepatitis Market and Competitive Landscape - 2021 - Product Thumbnail Image

Global Nonalcoholic Steatohepatitis Market and Competitive Landscape - 2021

  • Report
  • August 2021
From
Non-alcoholic Steatohepatitis (NASH) Therapeutics and Diagnostics Market Growth Analysis and Insights, 2021: Trends, Market Size, Share Outlook and Opportunities by Type, Application, End Users, Countries and Companies to 2028 - Product Thumbnail Image

Non-alcoholic Steatohepatitis (NASH) Therapeutics and Diagnostics Market Growth Analysis and Insights, 2021: Trends, Market Size, Share Outlook and Opportunities by Type, Application, End Users, Countries and Companies to 2028

  • Report
  • September 2021
  • 135 pages
From
Europe Nonalcoholic Steatohepatitis Market and Competitive Landscape - 2021 - Product Thumbnail Image

Europe Nonalcoholic Steatohepatitis Market and Competitive Landscape - 2021

  • Report
  • August 2021
From
Fatty Liver Disease - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Fatty Liver Disease - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • August 2021
  • 604 pages
From
Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) - Drugs in Development, 2021 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
From
Global Nonalcoholic Steatohepatitis Epidemiology and Patient Flow - 2021 - Product Thumbnail Image

Global Nonalcoholic Steatohepatitis Epidemiology and Patient Flow - 2021

  • Report
  • February 2021
From
Global Nonalcoholic Fatty Liver Disease Clinical Trial Pipeline Highlights - 2021 - Product Thumbnail Image

Global Nonalcoholic Fatty Liver Disease Clinical Trial Pipeline Highlights - 2021

  • Report
  • January 2021
From
Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H2 2020 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 1101 pages
From
Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2029) - Product Thumbnail Image

Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2029)

  • Report
  • July 2020
  • 102 Pages
From
NASH Biomarkers (Non alcoholic Steatohepatitis) Market Value forecast, New Business Opportunities and Companies: Outlook by Type, Application, by End User and by Country, 2020-2026 - Product Thumbnail Image

NASH Biomarkers (Non alcoholic Steatohepatitis) Market Value forecast, New Business Opportunities and Companies: Outlook by Type, Application, by End User and by Country, 2020-2026

  • Report
  • September 2020
From
Non-Alcoholic Steatohepatitis Market Analysis by Disease Cause, by Drug Type, by End-User and Segment Forecast to 2027 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis Market Analysis by Disease Cause, by Drug Type, by End-User and Segment Forecast to 2027

  • Report
  • August 2020
  • 225 pages
From
Non-Alcoholic Steatohepatitis - Epidemiology Forecast to 2029 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis - Epidemiology Forecast to 2029

  • Report
  • June 2020
  • 35 pages
From
Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • March 2020
  • 423 pages
From
NASH Biomarkers (Non alcoholic Steatohepatitis) Market Size, Outlook and Growth Opportunities, 2019- 2025 - Product Thumbnail Image

NASH Biomarkers (Non alcoholic Steatohepatitis) Market Size, Outlook and Growth Opportunities, 2019- 2025

  • Report
  • November 2019
From
Non-alcoholic Steatohepatitis (NASH) Therapeutics and Diagnostics Market - Growth, Trends, and Forecast (2019 - 2024) - Product Thumbnail Image

Non-alcoholic Steatohepatitis (NASH) Therapeutics and Diagnostics Market - Growth, Trends, and Forecast (2019 - 2024)

  • Report
  • May 2019
  • 114 pages
From
2019 Non-Alcoholic Steatohepatitis (NASH) Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets - Product Thumbnail Image

2019 Non-Alcoholic Steatohepatitis (NASH) Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • Clinical Trials
  • February 2019
  • 146 pages
From
Nonalcoholic Steatohepatitis Therapeutics in Asia-Pacific Markets to 2024 - Launch of NASH-Specific Premium Products and Rising Prevalence to Drive the Market - Product Thumbnail Image

Nonalcoholic Steatohepatitis Therapeutics in Asia-Pacific Markets to 2024 - Launch of NASH-Specific Premium Products and Rising Prevalence to Drive the Market

  • Report
  • December 2018
  • 112 Days
From
Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market: Industry Analysis & Outlook (2018-2027) - Product Thumbnail Image

Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market: Industry Analysis & Outlook (2018-2027)

  • Report
  • October 2018
  • 75 Pages
From
Fatty Liver Disease Ongoing Global Clinical Trials Analysis and Outlook - Product Thumbnail Image

Fatty Liver Disease Ongoing Global Clinical Trials Analysis and Outlook

  • Report
  • June 2018
  • 223 pages
From
Loading Indicator
adroll